This grant opportunity from the National Institutes of Health supports early- and late-stage clinical trials addressing the spectrum of Alzheimer's disease, Alzheimer's disease-related dementias, and age-related cognitive decline. The application deadline is May 19, 2026. Specific eligibility and funding amount details are not provided.
Eligibility details are not specified in the grant listing. Contact the funding organization for requirements.
